Silo Pharma's subsidiary, QwikAgents, has recently joined the AMD AI Developer Program, marking a significant advancement in its mission to develop AI-driven solutions for various users, including enterprises and individuals.
Through this collaboration, QwikAgents gains access to AMD's Developer Cloud, which offers advanced AI tools, training resources, and a supportive global community. This integration is expected to enhance QwikAgents' platform, enabling the development of persistent AI agents tailored for diverse applications such as content generation, scheduling, and workflow automation.
According to Eric Weisblum, CEO of Silo Pharma, this partnership is pivotal for accelerating the capabilities of QwikAgents, particularly in optimizing and deploying AI agents efficiently. The platform aims to provide affordable, user-friendly AI solutions designed for both personal and business use, with pricing starting at $14 per month.
As QwikAgents continues to evolve, the collaboration with AMD is anticipated to bolster its performance and reliability, facilitating the deployment of autonomous AI agents that can perform tasks with minimal human intervention. This development reflects a broader trend in the life sciences and technology sectors, where AI is increasingly being integrated into various operational workflows.